Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.

CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples

Abstract

The CD79 molecule, comprising two polypeptide chains, mb-1 (CD79a) and B29 (CD79b), is physically associated in the B-cell membrane with immunoglobulin. It transmits a signal after antigen binding and may, therefore, be considered the B cell equivalent of CD3. It appears before the pre-B-cell stage, and the mb-1 (CD79a) chain can still be present at the plasma cell stage. In this report, we describe a new anti-CD79a monoclonal antibody, JCB117, which reacts with human B cells in paraffin embedded tissue sections, including decalcified bone marrow trephines. When tested on a total of 454 paraffin embedded tissue biopsies, gathered from a number of different institutions, it reacted with the great majority (97%) of B-cell neoplasms, covering the full range of B-cell maturation, including 10 of 20 cases of myeloma/plasmacytoma. It is of interest that the antibody labels precursor B-cell acute lymphoblastic leukemia samples, making it the most reliable B-cell marker detectable in paraffin-embedded specimens in this disorder. All neoplasms of T cell or nonlymphoid origin were negative, indicating that antibody JCB117 may be of value to diagnostic histopathologists for the identification of B-cell neoplasms of all maturation stages.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood.v86.4.1453.bloodjournal8641453

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Cited by

See all 193

Metadata

Authors
Mason, D., Cordell, J., Brown, M., Borst, J., Jones, M., Pulford, K., Jaffe, E., Ralfkiaer, E., Dallenbach, F., & Stein, H.
Affiliations
John Radcliffe Hospital (GB)
Venue
Blood
Published
1995-08-15
Volume
86
Issue
4
Pages
1453-1459
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W39589595
Cited by
193
References
39
Citations by year
2026: 5 · 2025: 11 · 2024: 6 · 2023: 9 · 2022: 7 · 2021: 18 · 2020: 2 · 2019: 5 · 2017: 2 · 2016: 5 · 2015: 4 · 2014: 2 · 2013: 3 · 2012: 4
FWCI
5.90
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
CD79a, B-cell malignancies, paraffin-embedded tissue, B-cell markers, multiple myeloma, plasmacytoma, B-cell precursor acute lymphoblastic leukemia, B cell maturation, bone marrow trephine, immunohistochemistry
MeSH terms
Antibodies, Monoclonal, Antibodies, Neoplasm, Antibody Specificity, Antigens, Neoplasm, B-Lymphocytes, Humans, Immunohistochemistry, Paraffin, Receptors, Antigen, B-Cell, Biomarkers, Tumor, Leukemia, B-Cell, Antigens, CD, CD79 Antigens

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. https://app.cochat.ai/papers/10.1182/blood.v86.4.1453.bloodjournal8641453
The paper
Mason, D., Cordell, J., Brown, M., Borst, J., Jones, M., Pulford, K., Jaffe, E., Ralfkiaer, E., Dallenbach, F., & Stein, H. (1995). CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood. https://doi.org/10.1182/blood.v86.4.1453.bloodjournal8641453

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.